Researchers studied the effectiveness of new insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100) in patients with type 1 diabetes. In two small double-blind, randomized, crossover studies, insulin glargine concentration and glucose infusion rates were more constant and prolonged with Gla-300.